The PE Ratio as of December 2025 (TTM) for Neuland Laboratories Limited (NEULANDLAB.BO) is 90.09

According to Neuland Laboratories Limited’s latest financial reports and current stock price. The company's current PE Ratio is 90.09. This represents a change of -28.10% compared to the average of 125.29 of the last 4 quarters.

Neuland Laboratories Limited (NEULANDLAB.BO) Historical PE Ratio (quarterly & annually)

How has NEULANDLAB.BO PE Ratio performed in the past?

The mean historical PE Ratio of Neuland Laboratories Limited over the last ten years is 35.23. The current 90.09 PE Ratio has changed 25.47% with respect to the historical average. Over the past ten years (40 quarters), NEULANDLAB.BO's PE Ratio was at its highest in in the June 2018 quarter at 363.86. The PE Ratio was at its lowest in in the March 2020 quarter at -9.75.

Neuland Laboratories Limited (NEULANDLAB.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Neuland Laboratories Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neuland Laboratories Limited (NEULANDLAB.BO) Average PE Ratio

How has NEULANDLAB.BO PE Ratio performed in the past?

The current PE Ratio of Neuland Laboratories Limited (NEULANDLAB.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Neuland Laboratories Limited (NEULANDLAB.BO) PE Ratio vs. Peers

How is NEULANDLAB.BO’s PE Ratio compared to its peers?

Neuland Laboratories Limited’s PE Ratio is greater than Eris Lifesciences Limited (50.87), greater than Eris Lifesciences Limited (50.87), less than AstraZeneca Pharma India Limited (115.81), less than AstraZeneca Pharma India Limited (115.81), greater than Wockhardt Limited (-960.82), greater than Wockhardt Limited (-960.82), greater than Jubilant Pharmova Limited (35.60), greater than Piramal Enterprises Limited (43.81), greater than Jubilant Pharmova Limited (35.60), greater than Alembic Pharmaceuticals Limited (27.88),

Build a custom stock screener for Neuland Laboratories Limited (NEULANDLAB.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuland Laboratories Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neuland Laboratories Limited (NEULANDLAB.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neuland Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.